Product Images Ultomiris
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Ultomiris NDC 25682-025 by Alexion Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL - 30 mL Vial Carton - ultomiris 01
ultomiris 02
This text appears to provide information about a medication called ULTOMIRIS® and its dosage, dilution, and administration instructions. The medication is available in a 30 mL single-dose vial that must be diluted with 0.9% Sodium Chloride Injection prior to use. The medication should be protected from light and should not be frozen or shaken. The medication guide enclosed in the package must be dispensed to each patient. There is also information about the manufacturer of the medication, Alexion Pharmaceuticals, Inc.*
ultomiris 03
ultomiris 04
Ultomiris (ravulizumab-cwvz) is an injection for intravenous infusion containing 100 mg ravulizumab-cwvz, along with other ingredients. It must be administered through a 0.2 or 0.22-micron filter and does not contain preservatives. The drug should be stored at a temperature between 2°C and 8°C, and away from light. Alesion Pharmaceuticals Inc. manufactures Ultomiris. The prescribing information is available in a medication guide that should be given to each patient. The available lot is 932-01.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.